Digital Genome Market By Manufacturers, By Product (Sequencing & analyzer instruments, DNA/RNA analysis kits, Sequencing chips, Sequencing & analysis software, Sample preparation instruments), By application (Microbiology, Reproductive & Genetic, Transplantation, Livestock and Agriculture, Forensics, Research and Development), By End-user (Academic Research Institutes, Diagnostics & Forensic Labs, Hospitals, Bio-pharmaceutical Companies), and By Regions (North America, Europe, Middle East and Africa, Latin America and Asia Pacific) - Global Outlook to 2026
Report ID: 391290 | Feb 2020 | No. of Pages: 120
|
Covid-19 Impact Analysis & Forecast
Global Digital Genome Market is valued USD 28.69 Billion in 2019 and is projected is to exhibit 10.34% CAGR during the forecast period. The market is projected to be around USD 57.13 Billion by 2026. The market is driven by the rapid increase in the development of connected IoT devices.
The digital genome is a technology that deals with the genes and their functions help to find the causes behind chronic diseases, and also to fix them. The digital genome is a complete digital set of genetic material that presents an organism or cell. Technology is associated with the advancements that help to make healthcare more personal and more effective for the treatment.
Digital Genome Market Dynamics
The key factors that drive the growth of the digital genome market are the rising awareness of genetic roles in the identification of chronic disorders like cancer, rare disorders, diabetes, and others. Additionally, other vital factors affecting the development of the market are the growing aging population and the rise in demand for effective diagnosis of genetic disorders. Moreover, an increasing number of drug inventions and the upsurge in genomics research leading to an expansion of the market.
At the same time, the major factors restraining the growth of the digital genome market are lack of awareness regarding the digital genome, security & privacy of patient data, and incorrect results. Additionally, the lack of trained staff for the digital genome in various developing economies will further impede industry growth.
Digital Genome Market Insight
Based on the region, North America is expected to dominate the market of a Digital Genome, due to growing awareness and increasing the adoption of advanced technologies in the region. Furthermore, the Asia-Pacific region is expected to have the second-largest market during the forecast period. Due to the increasing incidence of chronic diseases, growing geriatric population, and rising focus on R&D activities in the region.
Digital Genome Market Segmentation
The global Digital Genome Market is segmented into product, application, end-user, and region. On the basis of the product the market is divided into sequencing & analyzer instruments, DNA/RNA analysis kits, sequencing chips, sequencing & analysis software, sample preparation instruments. Based on application the market is segmented into microbiology, reproductive & genetic, transplantation, livestock and agriculture, forensics, research and development. On the basis of the end-user the market is divided into academic research institutes, diagnostics & forensic labs, hospitals, bio-pharmaceutical companies. And based on the geography the market is further segregated into North America, Latin America, Europe and Asia Pacific.
Digital Genome Market Competitive Landscape
The key players in Digital Genome Market are listed as 10x Genomics, Thermo Fisher, BGI, Roche, Qiagen, Pac-Bio, PerkinElmer, Oxford Nanopore, Nanostring, Illumina, Bio-Rad, Agilent, Becton Dickinson, Sigma Aldrich, Fluidigm, Pacific, Biosciences, Veracyte, Trovagene, Affymetrix, Neogen, and Other.
The digital genome is a technology that deals with the genes and their functions help to find the causes behind chronic diseases, and also to fix them. The digital genome is a complete digital set of genetic material that presents an organism or cell. Technology is associated with the advancements that help to make healthcare more personal and more effective for the treatment.
Digital Genome Market Dynamics
The key factors that drive the growth of the digital genome market are the rising awareness of genetic roles in the identification of chronic disorders like cancer, rare disorders, diabetes, and others. Additionally, other vital factors affecting the development of the market are the growing aging population and the rise in demand for effective diagnosis of genetic disorders. Moreover, an increasing number of drug inventions and the upsurge in genomics research leading to an expansion of the market.
At the same time, the major factors restraining the growth of the digital genome market are lack of awareness regarding the digital genome, security & privacy of patient data, and incorrect results. Additionally, the lack of trained staff for the digital genome in various developing economies will further impede industry growth.
Digital Genome Market Insight
Based on the region, North America is expected to dominate the market of a Digital Genome, due to growing awareness and increasing the adoption of advanced technologies in the region. Furthermore, the Asia-Pacific region is expected to have the second-largest market during the forecast period. Due to the increasing incidence of chronic diseases, growing geriatric population, and rising focus on R&D activities in the region.
Digital Genome Market Segmentation
The global Digital Genome Market is segmented into product, application, end-user, and region. On the basis of the product the market is divided into sequencing & analyzer instruments, DNA/RNA analysis kits, sequencing chips, sequencing & analysis software, sample preparation instruments. Based on application the market is segmented into microbiology, reproductive & genetic, transplantation, livestock and agriculture, forensics, research and development. On the basis of the end-user the market is divided into academic research institutes, diagnostics & forensic labs, hospitals, bio-pharmaceutical companies. And based on the geography the market is further segregated into North America, Latin America, Europe and Asia Pacific.
Digital Genome Market Competitive Landscape
The key players in Digital Genome Market are listed as 10x Genomics, Thermo Fisher, BGI, Roche, Qiagen, Pac-Bio, PerkinElmer, Oxford Nanopore, Nanostring, Illumina, Bio-Rad, Agilent, Becton Dickinson, Sigma Aldrich, Fluidigm, Pacific, Biosciences, Veracyte, Trovagene, Affymetrix, Neogen, and Other.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. DefinitionChapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & LimitationsChapter 3. Executive SummaryChapter 4. Market Outlook
4.1. Market Dynamics
4.1.1. Market Drivers
4.1.2. Market Restraints
4.1.3. Market Opportunities
4.2. Porter’s Analysis
4.3. Value Chain AnalysisChapter 5. Digital Genome Market, By Product
5.1. Digital Genome Market, By Product, 2018-2026
5.2. Sequencing & analyzer instruments
5.3. DNA/RNA analysis kits
5.4. Sequencing chips
5.5. Sequencing & analysis software
5.6. Sample preparation instrumentsChapter 6. Digital Genome Market, By Application
6.1. Digital Genome Market, by Application, 2018-2026
6.2. Microbiology
6.3. Reproductive & Genetic
6.4. Transplantation
6.5. Livestock and Agriculture
6.6. Forensics
6.7. Research and DevelopmentChapter 7. Digital Genome Market, By End-user
7.1. Digital Genome Market, by End-user, 2018-2026
7.2. Academic Research Institutes
7.3. Diagnostics & Forensic Labs
7.4. Hospitals
7.5. Bio-pharmaceutical CompaniesChapter 8. Digital Genome Market, By Region
8.1. Digital Genome Market, by Region, 2018-2026
8.1.1. North America
8.1.1.1. U.S
8.1.1.2. Rest of North America
8.1.2. Europe
8.1.2.1. U.K.
8.1.2.2. Germany
8.1.2.3. France
8.1.2.4. Rest of the Europe
8.1.3. Middle East & Africa (MEA)
8.1.3.1. GCC
8.1.3.2. North Africa
8.1.3.3. South Africa
8.1.3.4. Rest of MEA
8.1.4. Latin America (LATAM)
8.1.4.1. Brazil
8.1.4.2. Rest of LATAM
8.1.5. Asia Pacific (APAC)
8.1.5.1. India
8.1.5.2. China
8.1.5.3. Japan
8.1.5.4. Rest of the APACChapter 10. Competitive Landscape
10.1.1. Key Strategies Adopted by Players
10.1.2. Market Share/Positioning AnalysisChapter 10. Company Profiles10.1. 10x Genomics.
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives10.2. Thermo Fisher
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives10.3. BGI
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives10.4. Roche
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives10.5 Qiagen
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives10.6. Pac-Bio
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives10.7. PerkinElmer
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives10.8. Oxford Nanopore
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives10.9. Nanostring
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives10.10. Illumina
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives10.11. Bio-Rad
10.11.1. Company Overview
10.11.2. Product Offerings
10.11.3. Financial Performance
10.11.4. Recent Initiatives10.12. Agilent
10.12.1. Company Overview
10.12.2. Product Offerings
10.12.3. Financial Performance
10.12.4. Recent Initiatives10.13. Becton Dickinson
10.13.1. Company Overview
10.13.2. Product Offerings
10.13.3. Financial Performance
10.13.4. Recent Initiatives10.14. Sigma Aldrich
10.14.1. Company Overview
10.14.2. Product Offerings
10.14.3. Financial Performance
10.14.4. Recent Initiatives10.15 Fluidigm
10.15.1. Company Overview
10.15.2. Product Offerings
10.15.3. Financial Performance
10.15.4. Recent Initiatives10.16. Pacific Biosciences
10.16.1. Company Overview
10.16.2. Product Offerings
10.16.3. Financial Performance
10.16.4. Recent Initiatives10.17. Veracyte
10.17.1. Company Overview
10.17.2. Product Offerings
10.17.3. Financial Performance
10.17.4. Recent Initiatives10.18. Trovagene
10.18.1. Company Overview
10.18.2. Product Offerings
10.18.3. Financial Performance
10.18.4. Recent Initiatives10.19. Affymetrix
10.19.1. Company Overview
10.19.2. Product Offerings
10.19.3. Financial Performance
10.19.4. Recent Initiatives10.20. Neogen
10.20.1. Company Overview
10.20.2. Product Offerings
10.20.3. Financial Performance
10.20.4. Recent Initiatives10.21. List of other companies
10.21.1. Company Overview
10.21.2. Product Offerings
10.21.3. Financial Performance
10.21.4. Recent InitiativesChapter 11. Appendix
11.1. About Us
11.2. Glossary of Terms
1.1. Research Objective
1.2. Scope of the Study
1.3. DefinitionChapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & LimitationsChapter 3. Executive SummaryChapter 4. Market Outlook
4.1. Market Dynamics
4.1.1. Market Drivers
4.1.2. Market Restraints
4.1.3. Market Opportunities
4.2. Porter’s Analysis
4.3. Value Chain AnalysisChapter 5. Digital Genome Market, By Product
5.1. Digital Genome Market, By Product, 2018-2026
5.2. Sequencing & analyzer instruments
5.3. DNA/RNA analysis kits
5.4. Sequencing chips
5.5. Sequencing & analysis software
5.6. Sample preparation instrumentsChapter 6. Digital Genome Market, By Application
6.1. Digital Genome Market, by Application, 2018-2026
6.2. Microbiology
6.3. Reproductive & Genetic
6.4. Transplantation
6.5. Livestock and Agriculture
6.6. Forensics
6.7. Research and DevelopmentChapter 7. Digital Genome Market, By End-user
7.1. Digital Genome Market, by End-user, 2018-2026
7.2. Academic Research Institutes
7.3. Diagnostics & Forensic Labs
7.4. Hospitals
7.5. Bio-pharmaceutical CompaniesChapter 8. Digital Genome Market, By Region
8.1. Digital Genome Market, by Region, 2018-2026
8.1.1. North America
8.1.1.1. U.S
8.1.1.2. Rest of North America
8.1.2. Europe
8.1.2.1. U.K.
8.1.2.2. Germany
8.1.2.3. France
8.1.2.4. Rest of the Europe
8.1.3. Middle East & Africa (MEA)
8.1.3.1. GCC
8.1.3.2. North Africa
8.1.3.3. South Africa
8.1.3.4. Rest of MEA
8.1.4. Latin America (LATAM)
8.1.4.1. Brazil
8.1.4.2. Rest of LATAM
8.1.5. Asia Pacific (APAC)
8.1.5.1. India
8.1.5.2. China
8.1.5.3. Japan
8.1.5.4. Rest of the APACChapter 10. Competitive Landscape
10.1.1. Key Strategies Adopted by Players
10.1.2. Market Share/Positioning AnalysisChapter 10. Company Profiles10.1. 10x Genomics.
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives10.2. Thermo Fisher
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives10.3. BGI
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives10.4. Roche
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives10.5 Qiagen
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives10.6. Pac-Bio
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives10.7. PerkinElmer
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives10.8. Oxford Nanopore
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives10.9. Nanostring
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives10.10. Illumina
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives10.11. Bio-Rad
10.11.1. Company Overview
10.11.2. Product Offerings
10.11.3. Financial Performance
10.11.4. Recent Initiatives10.12. Agilent
10.12.1. Company Overview
10.12.2. Product Offerings
10.12.3. Financial Performance
10.12.4. Recent Initiatives10.13. Becton Dickinson
10.13.1. Company Overview
10.13.2. Product Offerings
10.13.3. Financial Performance
10.13.4. Recent Initiatives10.14. Sigma Aldrich
10.14.1. Company Overview
10.14.2. Product Offerings
10.14.3. Financial Performance
10.14.4. Recent Initiatives10.15 Fluidigm
10.15.1. Company Overview
10.15.2. Product Offerings
10.15.3. Financial Performance
10.15.4. Recent Initiatives10.16. Pacific Biosciences
10.16.1. Company Overview
10.16.2. Product Offerings
10.16.3. Financial Performance
10.16.4. Recent Initiatives10.17. Veracyte
10.17.1. Company Overview
10.17.2. Product Offerings
10.17.3. Financial Performance
10.17.4. Recent Initiatives10.18. Trovagene
10.18.1. Company Overview
10.18.2. Product Offerings
10.18.3. Financial Performance
10.18.4. Recent Initiatives10.19. Affymetrix
10.19.1. Company Overview
10.19.2. Product Offerings
10.19.3. Financial Performance
10.19.4. Recent Initiatives10.20. Neogen
10.20.1. Company Overview
10.20.2. Product Offerings
10.20.3. Financial Performance
10.20.4. Recent Initiatives10.21. List of other companies
10.21.1. Company Overview
10.21.2. Product Offerings
10.21.3. Financial Performance
10.21.4. Recent InitiativesChapter 11. Appendix
11.1. About Us
11.2. Glossary of Terms
10x Genomics.
Thermo Fisher
BGI
Roche
Qiagen
Pac-Bio
PerkinElmer
Oxford Nanopore
Nanostring
Illumina
Bio-Rad
Agilent.
Becton Dickinson
Sigma Aldrich
Fluidigm
Pacific Biosciences
Veracyte
Trovagene
Affymetrix
Neogen.
Other
Thermo Fisher
BGI
Roche
Qiagen
Pac-Bio
PerkinElmer
Oxford Nanopore
Nanostring
Illumina
Bio-Rad
Agilent.
Becton Dickinson
Sigma Aldrich
Fluidigm
Pacific Biosciences
Veracyte
Trovagene
Affymetrix
Neogen.
Other
1. This report provides in depth analysis for changing competitive dynamics and keeps you ahead of competitors
2. Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market
3. It provides a forward looking perspective on different factors driving or restraining market growth
4. It provides an eight-year forecast assessed on the basis of how the market is expected to grow
5. It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of various market segment
6. Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Connect With Us
+1-707-633-0404
sales@search4research.com